Skip to main content
. 2023 Dec 4;14:1321233. doi: 10.3389/fpsyt.2023.1321233

Figure 3.

Figure 3

Course of the total scores of the Positive And Negative Syndrome Scale (PANSS) in the groups with comorbid substance use disorder (SUD) and the non-comorbid group (non-SUD). Both groups obtained >50% reduction from baseline to endpoint, compatible with clinical response, but similarly to what occurred with the BPRS-24, the non-SUD group scored constantly lower throughout the study, indicating that the non-comorbid group was clinically better than the comorbid SUD group.